Thrombolytic therapy for acute myocardial infarction. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Coronary Vessels Myocardium Heart Heart Ventricles Myocytes, Cardiac

Organisms1

Diseases67

Myocardial Infarction Acute Disease Infarction Cerebral Infarction Stroke Coronary Thrombosis Shock, Cardiogenic Recurrence Anterior Wall Myocardial Infarction Heart Rupture, Post-Infarction Ventricular Remodeling Thrombosis Hemorrhage Brain Ischemia Angina Pectoris Pulmonary Embolism Coronary Disease Cerebral Hemorrhage Angina, Unstable Chest Pain Ventricular Dysfunction, Left Myocardial Ischemia Heart Rupture Emergencies Arrhythmias, Cardiac Ventricular Septal Rupture Heart Failure Coronary Artery Disease Intracranial Hemorrhages Intracranial Thrombosis Cerebrovascular Disorders Heart Diseases Disease Models, Animal Inferior Wall Myocardial Infarction Intracranial Embolism and Thrombosis Acute Coronary Syndrome Embolism Myocardial Reperfusion Injury Edema, Cardiac Carotid Artery Thrombosis Intracranial Embolism Death, Sudden, Cardiac No-Reflow Phenomenon Diabetes Complications Coronary Stenosis Coronary Occlusion Venous Thrombosis Infarction, Middle Cerebral Artery Ventricular Fibrillation Eye Hemorrhage Heart Block Cardiovascular Diseases Coronary Vasospasm Arterial Occlusive Diseases Heart Aneurysm Death, Sudden Coronary Restenosis Bundle-Branch Block Infarction, Anterior Cerebral Artery Rupture, Spontaneous Thromboembolism Necrosis Ventricular Dysfunction, Right Diabetes Mellitus Convalescence Diabetic Angiopathies Cardiac Complexes, Premature

Chemicals and Drugs49

Streptokinase Fibrinolytic Agents Tissue Plasminogen Activator Creatine Kinase Anistreplase Plasminogen Activators Heparin Urokinase-Type Plasminogen Activator Platelet Aggregation Inhibitors Aspirin Biological Markers Anticoagulants Troponin T Immunoglobulin Fab Fragments Recombinant Proteins Adrenergic beta-Antagonists Troponin I Fibrinolysin Creatine Kinase, MB Form Hirudins Thallium Radioisotopes Fibrinogen Fibrinopeptide A Cardiovascular Agents Contrast Media Isoenzymes Cardiotonic Agents Ticlopidine Platelet Glycoprotein GPIIb-IIIa Complex Technetium Tc 99m Sestamibi Myoglobin Fibrin Angiotensin-Converting Enzyme Inhibitors Technetium Tc 99m Pyrophosphate Hydroxybutyrate Dehydrogenase Troponin Fibrin Fibrinogen Degradation Products Dobutamine Natriuretic Peptide, Brain Nicorandil Iodobenzenes Metoprolol C-Reactive Protein Plasminogen Enoxaparin Tocainide Streptodornase and Streptokinase Hydroxymethylglutaryl-CoA Reductase Inhibitors L-Lactate Dehydrogenase

Analytical, Diagnostic and Therapeutic Techniques and Equipment94

Thrombolytic Therapy Myocardial Reperfusion Angioplasty, Balloon, Coronary Electrocardiography Treatment Outcome Coronary Angiography Prospective Studies Risk Factors Hospital Mortality Follow-Up Studies Prognosis Predictive Value of Tests Retrospective Studies Stroke Volume Stents Myocardial Revascularization Echocardiography Survival Analysis Registries Hospitalization Cardiac Catheterization Multivariate Analysis Risk Assessment Thrombectomy Coronary Artery Bypass Incidence Survival Rate Infusions, Intravenous Clinical Enzyme Tests Hirudin Therapy Randomized Controlled Trials as Topic Percutaneous Coronary Intervention Proportional Hazards Models Embolectomy Cohort Studies Logistic Models Drug Therapy, Combination Emergency Treatment Injections, Intravenous Tomography, X-Ray Computed Intra-Aortic Balloon Pumping Radionuclide Ventriculography Tomography, Emission-Computed, Single-Photon Double-Blind Method Risk Sensitivity and Specificity Severity of Illness Index Regression Analysis Odds Ratio Chi-Square Distribution Patient Selection Disease Models, Animal Case-Control Studies Injections, Intra-Arterial Length of Stay Magnetic Resonance Imaging Infusions, Intra-Arterial Drug-Eluting Stents Patient Admission Reperfusion Angiography Patient Transfer Electrocardiography, Ambulatory Kaplan-Meier Estimate Transportation of Patients Patient Discharge Analysis of Variance Clinical Trials as Topic Cerebral Angiography Exercise Test Magnetic Resonance Imaging, Cine Random Allocation Heart Function Tests Angioplasty, Balloon Angioplasty Feasibility Studies Cause of Death Heart Rate Confidence Intervals Ultrasonography, Interventional Combined Modality Therapy Cineangiography Magnetic Resonance Angiography ROC Curve Vectorcardiography Pilot Projects Suction Catheterization, Peripheral Blood Pressure Drug Administration Schedule Treatment Failure Time-to-Treatment Catheterization Echocardiography, Doppler

Psychiatry and Psychology1

Phenomena and Processes22

Time Factors Ventricular Function, Left Ventricular Remodeling Coronary Circulation Stroke Volume Fibrinolysis Vascular Patency Risk Sensitivity and Specificity Odds Ratio Chi-Square Distribution Hemodynamics Tissue Survival Myocardial Contraction Heart Rate Blood Coagulation Recovery of Function Hemostasis Collateral Circulation Necrosis Microcirculation Blood Pressure

Disciplines and Occupations2

Outcome Assessment (Health Care)Cardiology

Technology, Industry, Agriculture1

Information Science5

Hospital Mortality Registries Incidence Survival Rate Cause of Death

Named Groups1

Emergency Medical Technicians

Health Care61

Treatment Outcome Coronary Care Units Prospective Studies Risk Factors Hospital Mortality Follow-Up Studies Predictive Value of Tests Retrospective Studies Emergency Medical Services Survival Analysis Registries Hospitalization Multivariate Analysis Risk Assessment Incidence Emergencies Survival Rate Randomized Controlled Trials as Topic Proportional Hazards Models Cohort Studies Logistic Models Age Factors Double-Blind Method Risk Sensitivity and Specificity Severity of Illness Index Regression Analysis Sex Factors Odds Ratio Chi-Square Distribution Patient Selection Case-Control Studies Length of Stay Emergency Medical Technicians Emergency Service, Hospital Hospitals, Community Patient Admission Cardiology Service, Hospital Patient Transfer Kaplan-Meier Estimate Transportation of Patients Patient Discharge Analysis of Variance Clinical Trials as Topic Outcome Assessment (Health Care)Random Allocation Feasibility Studies Cause of Death Ambulances Comorbidity Confidence Intervals Practice Guidelines as Topic ROC Curve Physician's Practice Patterns Confounding Factors (Epidemiology)Pilot Projects Medicare Treatment Failure Hospitals Time-to-Treatment Outcome and Process Assessment (Health Care)

Geographicals4

United States Japan Denmark Newfoundland and Labrador

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Thrombolytic Therapy Myocardial Infarction Streptokinase Fibrinolytic Agents Tissue Plasminogen Activator Myocardial Reperfusion Angioplasty, Balloon, Coronary Electrocardiography Time Factors Treatment Outcome Coronary Angiography Coronary Care Units Creatine Kinase Anistreplase Prospective Studies Acute Disease Plasminogen Activators Infarction Risk Factors Cerebral Infarction Stroke Hospital Mortality Coronary Thrombosis Shock, Cardiogenic Follow-Up Studies Heparin Prognosis Recurrence Anterior Wall Myocardial Infarction Ventricular Function, Left Heart Rupture, Post-Infarction Predictive Value of Tests Urokinase-Type Plasminogen Activator Ventricular Remodeling Thrombosis Retrospective Studies Hemorrhage Brain Ischemia Coronary Circulation Stroke Volume Angina Pectoris Platelet Aggregation Inhibitors Stents Pulmonary Embolism Coronary Vessels Myocardial Revascularization Myocardium Emergency Medical Services Coronary Disease Cerebral Hemorrhage Echocardiography Survival Analysis Aspirin Registries Angina, Unstable Hospitalization Cardiac Catheterization Multivariate Analysis Fibrinolysis Risk Assessment Chest Pain Biological Markers Thrombectomy Anticoagulants Ventricular Dysfunction, Left Coronary Artery Bypass Myocardial Ischemia Incidence Heart Rupture Emergencies Survival Rate Vascular Patency Arrhythmias, Cardiac Infusions, Intravenous Clinical Enzyme Tests Hirudin Therapy Randomized Controlled Trials as Topic Percutaneous Coronary Intervention Heart Proportional Hazards Models Embolectomy Ventricular Septal Rupture Heart Ventricles Cohort Studies Logistic Models Troponin T Heart Failure Coronary Artery Disease Drug Therapy, Combination Intracranial Hemorrhages Emergency Treatment Age Factors Injections, Intravenous Tomography, X-Ray Computed Intra-Aortic Balloon Pumping Radionuclide Ventriculography Immunoglobulin Fab Fragments Tomography, Emission-Computed, Single-Photon Intracranial Thrombosis Recombinant Proteins

No FAQ available that match "thrombolytic therapy for acute myocardial infarction"